TOP1 and cancer: TOP1 and PRP4 showed moderate elevation across cancer types, and the most pronounced changes for PRP4 were observed in thymoma and kidney chromophobe subtype while the most pronounced changed for TOP1 were observed in lung, stomach and esophagus, and uterine corpus endometrial carcinomas (56).